MRRS adds "Immune Pharmaceuticals Inc. (IMNP) – Financial and Strategic SWOT Analysis Review" latest studies, published in November 2016. It is a professional and in-depth study.
Summary
Immune Pharmaceuticals Inc. (Immune Pharma) formerly EpiCept Corporation, is a pharmaceutical company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The company’s bertilimumab is under clinical development for moderate to severe ulcerative colitis, crohn’s disease and bullous pemphigoid. It also offers nanomabs, which is an antibody nanoparticle conjugate technology platform for the targeted delivery of chemotherapeutics. Immune Pharma’s crolibulin is a small molecule vascular disrupting agent that is used for the treatment of solid tumors. The company develops drugs in the areas of immuno oncology, nano-dermatology and neuropathic pain. It has research and development facility in Herzliya-Pituach, Israel. Immune Pharma is headquartered in New York, the US.
The profile contains critical company information including*,
– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Browse Complete Report with TOC @
[URL]http://www.marketresearchreportstore.com/shop/immune-pharmaceuticals-inc-imnp-financial-and-strategic-swot-analysis-review-2[URL]

About Market Research Report Store
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.

Any questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S Helen
Email: Helen Mo
[email protected] or
[email protected]
http://www.marketresearchreportstore.com/